These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8297658)

  • 1. Mammographic patterns in breast cancer chemoprevention with fenretinide (4-HPR).
    Cassano E; Coopmans de Yoldi G; Ferranti C; Costa A; Mascotti G; De Palo G; Veronesi U
    Eur J Cancer; 1993; 29A(15):2161-3. PubMed ID: 8297658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention trial of contralateral breast cancer with fenretinide. Rationale, design, methodology, organization, data management, statistics and accrual.
    De Palo G; Camerini T; Marubini E; Costa A; Formelli F; Del Vecchio M; Mariani L; Miceli R; Mascotti G; Magni A; Campa T; Di Mauro MG; Attili A; Maltoni C; Del Turco MR; Decensi A; D'Aiuto G; Veronesi U
    Tumori; 1997; 83(6):884-94. PubMed ID: 9526578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenretinide breast cancer prevention trial: drug and retinol plasma levels in relation to age and disease outcome.
    Formelli F; Camerini T; Cavadini E; Appierto V; Villani MG; Costa A; De Palo G; Di Mauro MG; Veronesi U
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):34-41. PubMed ID: 12540501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.
    Veronesi U; De Palo G; Marubini E; Costa A; Formelli F; Mariani L; Decensi A; Camerini T; Del Turco MR; Di Mauro MG; Muraca MG; Del Vecchio M; Pinto C; D'Aiuto G; Boni C; Campa T; Magni A; Miceli R; Perloff M; Malone WF; Sporn MB
    J Natl Cancer Inst; 1999 Nov; 91(21):1847-56. PubMed ID: 10547391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenretinide (4-HPR) in chemoprevention of oral leukoplakia.
    Chiesa F; Tradati N; Marazza M; Rossi N; Boracchi P; Mariani L; Formelli F; Giardini R; Costa A; De Palo G
    J Cell Biochem Suppl; 1993; 17F():255-61. PubMed ID: 8412202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of local relapses and new localisations of oral leukoplakias with the synthetic retinoid fenretinide (4-HPR). Preliminary results.
    Chiesa F; Tradati N; Marazza M; Rossi N; Boracchi P; Mariani L; Clerici M; Formelli F; Barzan L; Carrassi A
    Eur J Cancer B Oral Oncol; 1992 Oct; 28B(2):97-102. PubMed ID: 1306735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patients.
    Torrisi R; Pensa F; Orengo MA; Catsafados E; Ponzani P; Boccardo F; Costa A; Decensi A
    Cancer Res; 1993 Oct; 53(20):4769-71. PubMed ID: 8402658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size, node status and grade of breast tumours: association with mammographic parenchymal patterns.
    Sala E; Solomon L; Warren R; McCann J; Duffy S; Luben R; Day N
    Eur Radiol; 2000; 10(1):157-61. PubMed ID: 10663736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide.
    Sabichi AL; Modiano MR; Lee JJ; Peng YM; Xu MJ; Villar H; Dalton WS; Lippman SM
    Clin Cancer Res; 2003 Jul; 9(7):2400-5. PubMed ID: 12855611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of breast cancer with retinoids.
    Veronesi U; De Palo G; Costa A; Formelli F; Marubini E; Del Vecchio M
    J Natl Cancer Inst Monogr; 1992; (12):93-7. PubMed ID: 1535505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between plasma transforming growth factor-beta 1 and second primary breast cancer in a chemoprevention trial.
    Decensi A; Torrisi R; Fontana V; Barreca A; Ponzani P; Pensa F; Parodi S; Costa A
    Eur J Cancer; 1998 Jun; 34(7):999-1003. PubMed ID: 9849446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast parenchymal patterns in women with bilateral primary breast cancer.
    Chaudary MA; Gravelle IH; Bulstrode JC; Wang DY; Bulbrook RD; Millis RR; Hayward JL
    Br J Radiol; 1983 Oct; 56(670):703-6. PubMed ID: 6616133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality control for HPLC assay and surrogate end point biomarkers from the fenretinide (4-HPR) breast cancer prevention trial.
    Formelli F
    J Cell Biochem Suppl; 2000; 34():73-9. PubMed ID: 10762018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic retinoid fenretinide in breast cancer chemoprevention.
    Bonanni B; Lazzeroni M; Veronesi U
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):423-32. PubMed ID: 17428163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic parenchymal patterns in Asian and Caucasian women attending for screening.
    Turnbull AE; Kapera L; Cohen ME
    Clin Radiol; 1993 Jul; 48(1):38-40. PubMed ID: 8370218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of "high risk" mammographic patterns to histological risk factors for development of cancer in the human breast.
    Arthur JE; Ellis IO; Flowers C; Roebuck E; Elston CW; Blamey RW
    Br J Radiol; 1990 Nov; 63(755):845-9. PubMed ID: 2252976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer chemoprevention.
    Costa A
    Eur J Cancer; 1993; 29A(4):589-92. PubMed ID: 8382073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of breast cancer and changes in mammographic parenchymal patterns over time.
    Salminen TM; Saarenmaa IE; Heikkilä MM; Hakama M
    Acta Oncol; 1998; 37(6):547-51. PubMed ID: 9860312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenretinide and risk reduction of second breast cancer.
    Decensi A; Zanardi S; Argusti A; Bonanni B; Costa A; Veronesi U
    Nat Clin Pract Oncol; 2007 Feb; 4(2):64-5. PubMed ID: 17259924
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast cancer chemoprevention: studies with 4-HPR alone and in combination with tamoxifen using circulating growth factors as potential surrogate endpoints.
    Decensi A; Formelli F; Torrisi R; Costa A
    J Cell Biochem Suppl; 1993; 17G():226-33. PubMed ID: 8007703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.